Aktie A2QPQR THIE POIN
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen THIE POIN

Aktien

A2QPQR

US88408P1075

THMA

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Thimble Point Acquisition : INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
Thimble Point Acquisition, Pear Therapeutics Close SPAC Merger; Combined Firm to Begin Trading Monday
Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company
Thimble Point Acquisition Corp.(NasdaqCM:THMA) dropped from NASDAQ Composite Index
Pear Therapeutics, Inc. completed the acquisition of Thimble Point Acquisition Corp. from LJ10 LLC and others in a reverse merger transaction.
THIMBLE POINT ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)
THIMBLE POINT ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)
Pear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx Conference
THIMBLE POINT ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
Pear Therapeutics Receives FDA Breakthrough Designation for reSET-A
Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder
Thimble Point Acquisition : Lock-Up Agreement - Form 8-K
THIMBLE POINT ACQUISITION CORP. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance
Thimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business Plan
Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List
Pear Therapeutics to Participate in the BTIG Digital Health Forum
Thimble Point Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
THIMBLE POINT ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Thimble Point Acquisition : Pear and Thimble Point Announce Nominees to Board of Directors
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QPQR Aktie
  4. Nachrichten THIE POIN
  5. Andere Sprachen